急性心肌梗死心源性猝死患者的血栓成分分析
TIDE研究纳入121例血管造影证实急性冠状动脉闭塞的STEMI患者,其中23例合并心源性猝死(SCD组)、98例未合并(STEMI组),通过血栓抽吸获取血栓并用扫描电镜定量分析。SCD组与STEMI组血栓中纤维蛋白纤维、血小板、红细胞、白细胞含量均无显著差异。使用糖蛋白IIb/IIIa受体抑制剂与否血栓成分无差异。早期就诊者(缺血时间<3小时)与晚期就诊者(>6小时)相比,纤维蛋白纤维含量降低(57.8±18.5% vs 71.9±10.1%,p=0.0008)、血小板含量升高(19.2±19.1% vs 7.9±5.7%,p=0.014)。
要点
- SCD组(n=23)与STEMI组(n=98)血栓成分无差异:纤维蛋白纤维60.3±18.4% vs 62.4±18.4%(p=0.68),血小板16.3±19.2% vs 15.6±16.7%(p=0.76)。
- 红细胞含量SCD组14.6±12.5% vs STEMI组13±12.1%(p=0.73),白细胞0.6±0.9% vs 0.8±1.5%(p=0.93),均无显著差异。
- 使用与未使用上游糖蛋白IIb/IIIa受体抑制剂的患者血栓成分无差异。
- 早期就诊者(缺血时间<3小时)vs 晚期就诊者(>6小时):纤维蛋白纤维57.8±18.5% vs 71.9±10.1%(p=0.0008),血小板19.2±19.1% vs 7.9±5.7%(p=0.014)。
适用人群与场景
- 血管造影证实急性冠状动脉闭塞的STEMI患者,合并心源性猝死(SCD组)或未合并(STEMI组)。
研究设计与关键结果
- TIDE研究纳入121例STEMI患者,SCD组23例、STEMI组98例,血栓经血栓抽吸获取并用扫描电镜定量分析。
- SCD组与STEMI组血栓成分无差异:纤维蛋白纤维60.3±18.4% vs 62.4±18.4%(p=0.68),血小板16.3±19.2% vs 15.6±16.7%(p=0.76),红细胞14.6±12.5% vs 13±12.1%(p=0.73),白细胞0.6±0.9% vs 0.8±1.5%(p=0.93)。
- 使用与未使用上游糖蛋白IIb/IIIa受体抑制剂的患者血栓成分无差异。
- 早期就诊者(缺血时间<3小时)vs 晚期就诊者(>6小时):纤维蛋白纤维57.8±18.5% vs 71.9±10.1%(p=0.0008),血小板19.2±19.1% vs 7.9±5.7%(p=0.014)。
证据类型、等级与局限
- 研究类型:TIDE研究,病例对照分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,症状发作至冠状动脉再灌注的时间似乎是影响MI血栓成分的最强因素。
- STEMI患者是否发生SCD与冠状动脉内血栓成分无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND AIM: It was hypothesized that the pattern of coronary occlusion (thrombus composition) might contribute to the onset of ventricular arrhythmia and sudden cardiac death (SCD) in myocardial infarction (MI).
METHODS: The TIDE (Thrombus and Inflammation in sudden DEath) study included patients with angiographically-proven acute coronary occlusion as the cause of a ST elevation MI (STEMI) complicated by Sudden Cardiac Death (SCD group) or not (STEMI group). Thrombi were obtained by thrombo-aspiration before primary percutaneous coronary stenting and analyzed with a quantitative method using scanning electron microscopy. We compared the composition of the thrombi responsible for the coronary occlusion between the two groups and evaluated factors influencing its composition.
RESULTS: We included 121 patients and found that thrombus composition was not different between the SCD group (n=23) and the STEMI group (n=98) regarding content of fibrin fibers (60.3±18.4% vs. 62.4±18.4% respectively, p=0.68), platelets (16.3±19.2% vs. 15.616.7±%, p=0.76), erythrocytes (14.6±12.5% vs. 13±12.1%, p=0.73) and leukocytes (0.6±0.9% vs. 0.8±1.5%, p=0.93). Thrombus composition did not differ between patients receiving upstream-use of glycoprotein IIb/IIIa platelet receptor inhibitors (GPI) and patients free of GPI. The only factor found to influence thrombus composition was the ischemic time from symptom onset to primary PCI, with a decreased content in fibrin fibers (57.8±18.5% vs. 71.9±10.1%, p=0.0008) and a higher platelet content (19.2±19.1% vs. 7.9±5.7% p=0.014) in early presenters (<3h of ischemic time) vs. late presenters (>6h of ischemic time).
CONCLUSION: Composition of intracoronary thrombi in STEMI patients does not differ between those presenting with and without SCD. Time from symptom onset to coronary reperfusion seems to be the strongest factor influencing thrombus composition in MI.
参考来源
- Silvain J, Collet JP, Guedeney P, et al. Thrombus composition in sudden cardiac death from acute myocardial infarction. Resuscitation. 2017. PMID: 28212919. doi:10.1016/j.resuscitation.2017.01.030
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。